echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The new mRNA vaccine is available in Hong Kong, China: cold chains and adverse reactions are no longer a problem

    The new mRNA vaccine is available in Hong Kong, China: cold chains and adverse reactions are no longer a problem

    • Last Update: 2021-03-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'> 310,。,:1.
    66000。

    310,。,:1.
    66000。544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>,29,8,21。,29,8,21。544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>“,”,。,:“,。”“,”,。,:“,。”544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>:,,,。,。:,,,。,。544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>125,。750,,。125,。750,,。,。544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>310,,。,。,mRNA。310,,。,。,mRNA。mRNA。544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>mRNA?。mRNA?。

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;white-space:normal;background-color:#FFFFFF;line-height:2em;text-align:center;box-sizing:border-box ;'>

    544px;white-space:normal;background-color:#FFFFFF;line-height:2em;text-align:center;box-sizing:border-box ;'>

    544px;white-space:normal;background-color:#FFFFFF;line-height:2em;text-align:center;box-sizing:border-box ;'> 2-8℃5

    2-8℃52-8℃5

    544px;white-space:normal;background-color:#FFFFFF;line-height:2em;text-align:center;box-sizing:border-box ;'>


    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Just a year ago, on March 13th, Fosun Pharma and BioNTech of Germany reached a strategic cooperation to jointly develop and commercialize vaccine products against the new coronavirus based on BioNTech's proprietary mRNA technology platform in the Greater China region.

    Just a year ago, on March 13th, Fosun Pharma and BioNTech of Germany reached a strategic cooperation to jointly develop and commercialize vaccine products against the new coronavirus based on BioNTech's proprietary mRNA technology platform in the Greater China region.


    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Fubital is an mRNA vaccine, which must be delivered in a deep-frozen state at -75°C, and the transportation and storage requirements involved are more complicated.

    Fubitai is an mRNA vaccine and must be delivered in a deep-frozen state at -75°C.


    Fubitai is an mRNA vaccine and must be delivered in a deep-frozen state at -75°C.
    The transportation and storage requirements involved are more complicated.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> On the morning of February 27, a cargo plane departing from Frankfurt landed at the Hong Kong International Airport.


    The "special passengers" on this cargo plane were the first batch of Fubitai vaccines.
    In order to inspect the situation of this batch of vaccines, the Secretary for Civil Service of Hong Kong, Nie Dequan, and the Secretary for Food and Health, Professor Chen Zhaoshi, came to meet the plane in person.


    On the morning of February 27, a cargo plane departing from Frankfurt landed at the Hong Kong International Airport.
    The "special passengers" on this cargo plane were the first batch of Fubitai vaccines.
    In order to inspect the situation of this batch of vaccines, the Secretary for Civil Service of Hong Kong, Nie Dequan, and the Secretary for Food and Health, Professor Chen Zhaoshi, came to meet the plane in person.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;white-space:normal;background-color:#FFFFFF;text-align:center;box-sizing:border-box ;overflow-wrap:break-word ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> After the "Fubitai" vaccine arrived, the staff immediately inspected and verified the vaccine to ensure that the vaccine complies with product specifications and relevant cold chain transportation standards.

    After the "Fubitai" vaccine arrived, the staff immediately inspected and verified the vaccine to ensure that the vaccine complies with product specifications and relevant cold chain transportation standards.


    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Fubitai is one of the two new crown vaccines that are allowed to be vaccinated in Hong Kong.


    As soon as the plane lands, the vaccine will be discharged first, and a special transport vehicle will transfer it to the central storage warehouse and transfer it to a -75°C freezer for storage.


    Fubitai is one of the two new crown vaccines that are allowed to be vaccinated in Hong Kong.
    As soon as the plane lands, the vaccine will be discharged first, and a special transport vehicle will transfer it to the central storage warehouse and transfer it to a -75°C freezer for storage.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Hui Aimin told the Health and Health Bureau that the vaccine will be placed in a special refrigerated transport box during the period from the time Fubitel leaves the factory to the time it arrives in the refrigerator.


    "This box is equipped with a temperature monitor and has dry ice to maintain a temperature of -75°C.
    As long as the dry ice is replaced every five days, the vaccine can be effectively stored in this box for one month.
    After being transferred to the refrigerator, the effective period is guaranteed.
    6 months.
    "

    Hui Aimin told the Health and Health Bureau that the vaccine will be placed in a special refrigerated transport box during the period from the time Fubitai leaves the factory to the time it arrives in the refrigerator.
    "This box is equipped with a temperature monitor and dry ice to maintain a temperature of -75°C.
    As long as the dry ice is replaced every five days, the vaccine can be effectively stored in this box for one month.
    And there is dry ice to maintain a temperature of -75°C, as long as every five days.
    If the dry ice is replaced once a day, the vaccine can be effectively stored in this box for one month.
    After being transferred to the freezer, the guaranteed validity period is 6 months.
    "

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> In the cold chain transportation link, Fosun Pharma cooperates with a professional logistics company in Hong Kong to ensure the transportation, storage and distribution of vaccines after they arrive in Hong Kong.


    Before the vaccine is transported from the central transportation station to each vaccination point, the temperature needs to be thawed to 2-8°C.
    , after inoculation with a maintenance arrived at the transport case 2-8 ℃ properties, but also good in this storage temperature is maintained for 5 days.


    In the cold chain transportation link, Fosun Pharma cooperates with a professional logistics company in Hong Kong to ensure the transportation, storage and distribution of vaccines after they arrive in Hong Kong.
    Before the vaccine is transported from the central transportation station to each vaccination point, the temperature needs to be thawed to 2-8°C.
    , after inoculation with a maintenance arrived at the transport case 2-8 ℃ properties, but also good in this storage temperature is maintained for 5 days.
    After being transported to the inoculation site in a transport box maintained at 2-8°C, it can be stored at this well-maintained temperature for 5 days.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Hui Aimin said: "A few months before entering Hong Kong, Fosun was preparing for Fubitai's logistics issues.


    All refrigeration and cold transportation have already been prepared, everything is ready, and we are waiting for the east wind.
    "

    Hui Aimin said: "A few months before entering Hong Kong, Fosun was preparing for Fubitai's logistics issues.
    All refrigeration and cold transportation have already been prepared, everything is ready, and we are waiting for the east wind.
    "

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Fubitel's specific storage location in Hong Kong is in the Kwai Chung warehouse.


    Its logistics services and facilities have obtained relevant important certifications such as ISO 9001, C-TPAT and TAPA, and also comply with GMQ standards.
    The entire process is strictly managed, tested and recorded by the quality department.
    .


    Fubitel's specific storage location in Hong Kong is in the Kwai Chung warehouse.


    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> The Hong Kong government emphasized that it has conducted exercises on vaccination work, including cold chain processing, transportation, storage, and vaccination procedures for Fubitel vaccine.


    After being vaccinated, citizens need to stay in the center for observation for 15 to 30 minutes before leaving.


    The Hong Kong government emphasized that it has conducted exercises on vaccination work, including cold chain processing, transportation, storage, and vaccination procedures for Fubitel vaccine.
    The vaccination work has been drilled, including the cold chain processing, transportation, storage, and vaccination process of Fubitel vaccine.
    After being vaccinated, citizens need to stay in the center for observation for 15 to 30 minutes before leaving.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> "Fobitai has been approved for emergency use in Hong Kong, China, and we are very excited and encouraged.
    This is also an important milestone for Fosun Pharma and BioNTech to work together to achieve the global availability of vaccines.
    " Said Wu Yifang, Chief Executive Officer.

    "Fobitai has been approved for emergency use in Hong Kong, China, and we are very excited and encouraged.
    This is also an important milestone for Fosun Pharma and BioNTech to work together to achieve the global availability of vaccines.
    " Said Wu Yifang, Chief Executive Officer.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;white-space:normal;background-color:#FFFFFF;line-height:2em;text-align:center;box-sizing:border-box ;'>

    544px;white-space:normal;background-color:#FFFFFF;line-height:2em;text-align:center;box-sizing:border-box ;'> The elderly and patients with chronic diseases can be vaccinated

    The elderly and patients with chronic diseases can be vaccinated

    544px;white-space:normal;background-color:#FFFFFF;line-height:2em;text-align:center;box-sizing:border-box ;'> It can also prevent asymptomatic infections

    It can also prevent asymptomatic infections

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Fubitel can be authorized to use by the health regulatory authorities of more than 60 countries and regions including the United Kingdom, the United States, Canada, and the European Union.
    One of the advantages is the 95% protection rate.

    Fubitel can be authorized to use by the health regulatory authorities of more than 60 countries and regions including the United Kingdom, the United States, Canada, and the European Union.
    One of the advantages is the 95% protection rate.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> In addition, Hui Aimin said: "Fubitai can effectively prevent asymptomatic infections, prevent severe infections, significantly reduce the hospitalization rate and mortality, and can be used for the elderly and patients with stable chronic diseases.

    In addition, Hui Aimin said: "Fubitai can effectively prevent asymptomatic infections, prevent severe infections, significantly reduce the hospitalization rate and mortality, and can be used for the elderly and patients with stable chronic diseases.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> This statement is supported by real-world data.
    In a set of real-world studies involving nearly 1.
    2 million people from Israel, nearly 600,000 people were vaccinated with the mRNA vaccine of Fubitai (English trade name: COMIRNATY ® ).
    Data show that the protection rate of symptomatic infections is as high as 94%, and the protection rate of all infected people (including symptomatic and asymptomatic) is 92%, which proves that "Fubitai can prevent asymptomatic infections and eliminate hidden dangers of transmission.
    " In addition, Fubitai can also prevent severe infections and reduce hospitalization and mortality.

    This statement is supported by real-world data.
    In a group of real-world studies involving nearly 1.
    2 million people in Israel, nearly 600,000 people were vaccinated with Forbitux this mRNA vaccine.
    In a group of real-world studies involving nearly 1.
    2 million people from Israel, nearly 600,000 people were vaccinated by Forbitux.
    This mRNA vaccine (English trade name: COMIRNATY ® ).
    Data show that the protection rate of symptomatic infections is as high as 94%, and the protection rate of all infected people (including symptomatic and asymptomatic) is 92%, which proves that "Fubitai can prevent asymptomatic infections and eliminate hidden dangers of transmission.
    " In addition, Fubitai can also prevent severe infections and reduce hospitalization and mortality.
    ®

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Previously, the public had always had doubts about whether the elderly and people with underlying diseases could be vaccinated against the new crown vaccine.
    In fact, Israel's mRNA vaccination covers the elderly, and 76% of the 600,000 vaccinators are high-risk groups , that is, high-risk groups with chronic diseases such as cancer, chronic kidney disease, chronic respiratory disease, heart disease, diabetes, and asthma.
    , More than 22,000 people were vaccinated for people over 80 years old.
    On the whole, these people have good safety after vaccination, and the adverse reactions are within an acceptable range.

    Previously, the public had always had doubts about whether the elderly and people with underlying diseases could be vaccinated against the new crown vaccine.
    In fact, the mRNA vaccination in Israel covers the elderly, and 76% of the 600,000 vaccinators are high-risk groups.
    The mRNA vaccination covers the elderly, and 76% of the 600,000 vaccinators are high-risk groups , that is, suffering from cancer and chronic diseases.
    More than 22,000 people have been vaccinated in high-risk groups of chronic diseases such as kidney disease, chronic respiratory disease, heart disease, diabetes, and asthma.
    Only the elderly over 80 years old have been vaccinated.
    On the whole, these people have good safety after vaccination, and the adverse reactions are within an acceptable range.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> However, Hui Aimin also emphasized: “If you are a very weak, acute-onset chronic disease patient, it is not recommended to vaccinate in a hurry.
    If you must vaccinate, you need to be cautious.
    For these people, you can strengthen the vaccination of the surrounding population.
    They built a protective wall.
    "

    However, Hui Aimin also emphasized: “If you are a very weak, acute-onset chronic disease patient, it is not recommended to vaccinate in a hurry.
    If you must vaccinate, you need to be cautious.
    For these people, you can strengthen the vaccination of the surrounding population.
    They built a protective wall.
    By strengthening the inoculation of the surrounding people, they built a protective wall for them.
    "

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;white-space:normal;background-color:#FFFFFF;text-align:center;box-sizing:border-box ;overflow-wrap:break-word ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> The Phase III clinical data of this mRNA vaccination published by the New England Journal of Medicine showed that after 1 shot, the vaccine began to produce obvious protective effects on 12 days, and the protection rate could reach 52% after 1 shot.
    For this data, Hui Aimin is very proud.
    According to the requirements of the World Health Organization, a new crown vaccine with a protection rate of more than 50% is effective.
    Fosun mRNA vaccine can be achieved with one shot, but in order to maximize the protection benefits, a second shot is still needed.

    The Phase III clinical data of this mRNA vaccination published by the New England Journal of Medicine showed that after 1 shot, the vaccine began to produce obvious protective effects on 12 days, and the protection rate could reach 52% after 1 shot.
    After 1 shot, obvious vaccine protection begins to occur within 12 days, and the protection rate can reach 52% after 1 shot.
    For this data, Hui Aimin is very proud.
    According to the requirements of the World Health Organization, a new crown vaccine with a protection rate of more than 50% is effective.
    Fosun mRNA vaccine can be achieved with one shot, but in order to maximize the protection benefits, a second shot is still needed.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>
    Among the 600,000 vaccinated people in Israel, even 1,500 pregnant women, the mRNA vaccine has also withstood the test of safety.
    Hui Aimin said: “There is currently no evidence that this vaccine will have adverse effects on pregnant women and fetuses, but for safety reasons, pregnant women should be cautious about vaccination before the results of rigorously designed clinical trials come out.

    Among the 600,000 vaccinated people in Israel, even 1,500 pregnant women, the mRNA vaccine has also withstood the test of safety.
    Among the 600,000 vaccinated people in Israel, even 1,500 pregnant women, the mRNA vaccine has also withstood the test of safety.
    Hui Aimin said: “There is currently no evidence that this vaccine will have adverse effects on pregnant women and fetuses, but for safety reasons, pregnant women should be cautious about vaccination before the results of rigorously designed clinical trials come out.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> At present, more than 1.
    34 million doses of the mRNA vaccine "Fubitai" jointly developed by Fosun Pharma and German BioNTech have arrived in Hong Kong.
    As of March 6, 96,000 people in Hong Kong have made appointments for vaccination with Fubitel.

    At present, more than 1.
    34 million doses of the mRNA vaccine "Fubitai" jointly developed by Fosun Pharma and German BioNTech have arrived in Hong Kong.
    As of March 6, 96,000 people in Hong Kong have made appointments for vaccination with Fubitel.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;white-space:normal;background-color:#FFFFFF;text-align:center;box-sizing:border-box ;'>

    544px;white-space:normal;background-color:#FFFFFF;line-height:2em;text-align:center;box-sizing:border-box ;'> Coincident events need scientific guidance

    Coincident events require scientific guidance Coincident events require scientific guidance544px;white-space:normal;background-color:#FFFFFF;text-align:center;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>An independent third-party analysis team in Hong KongAn independent third-party analysis team in Hong Kong An independent third-party analysis team in Hong Kong An independent third- party analysis team in Hong Kong544px;white-space:normal;background-color:#FFFFFF;text-align:center;line-height:2em;box-sizing:border-box ;overflow-wrap:break-word ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Hui Aimin also expressed his views on the serious adverse events after vaccination in various countries.

    Hui Aimin also expressed his views on the serious adverse events after vaccination in various countries.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> "Vaccinations in large groups will have incidents, rare complications and other problems.
    " Hui Aimin admitted frankly that even if there are millions of samples, it is difficult to predict what will happen when the samples reach tens of millions or hundreds of millions.
    Such rare serious adverse events.

    "Vaccinations in large groups will have incidents, rare complications and other problems.
    " Hui Aimin admitted frankly that even if there are millions of samples, it is difficult to predict what will happen when the samples reach tens of millions or hundreds of millions.
    Such rare serious adverse events.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Fosun Pharma's attitude is: if there is a problem, don't avoid it, respect the facts, analyze it scientifically, seek truth from facts, and guide it scientifically.

    Fosun Pharma's attitude is: if there is a problem, don't avoid it, respect the facts, analyze it scientifically, seek truth from facts, and guide it scientifically.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> The mRNA vaccine uses part of the gene sequence of the virus, not the virus itself, so it does not contain viral components and there is no risk of infection.
    But precisely because it does not take the usual route, its safety is widely discussed.

    The mRNA vaccine uses part of the gene sequence of the virus, not the virus itself, so it does not contain viral components and there is no risk of infection.
    Contains no viral components and there is no risk of infection.
    But precisely because it does not take the usual route, its safety is widely discussed.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Before the formal vaccination of Fubitel in Hong Kong, Fosun Pharma has set up a special safety alert team, provided detailed instructions, and trained medical staff at all vaccination sites to ensure timely and effective treatment when problems occur.
    In addition, a 24-hour hotline service has been opened, and citizens can use Mandarin, Cantonese, and English to consult common questions.
    Fosun Pharma has equipped the hotline service with a medical information team and a troubleshooting team.

    Before the formal vaccination of Fubitel in Hong Kong, Fosun Pharma has set up a special safety alert team, provided detailed instructions, and trained medical staff at all vaccination sites to ensure timely and effective treatment when problems occur.
    In addition, a 24-hour hotline service has been opened, and citizens can use Mandarin, Cantonese, and English to consult common questions.
    Fosun Pharma has equipped the hotline service with a medical information team and a troubleshooting team.
    Fosun Pharma has equipped a medical information team and a troubleshooting team for the hotline service.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;white-space:normal;background-color:#FFFFFF;text-align:center;box-sizing:border-box ;'>


    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Even with complete preparations, according to past data, a certain proportion of adverse reactions after vaccination is inevitable, otherwise it is not a vaccine.
    Fosun Pharma will collect and analyze the data of each adverse reaction, and report it to the relevant departments of the Hong Kong government.
    At the same time, foreign safety data including new rare adverse reactions and safety hazards are reported to the Hong Kong government every month.

    Even with complete preparations, according to past data, a certain proportion of adverse reactions after vaccination is inevitable, otherwise it is not a vaccine.
    Fosun Pharma will collect and analyze the data of each adverse reaction, and report it to the relevant departments of the Hong Kong government.
    Fosun Pharma will collect and analyze the data of each adverse reaction, and report it to the relevant departments of the Hong Kong government.
    At the same time, foreign safety data including new rare adverse reactions and safety hazards are reported to the Hong Kong government every month.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> Correspondingly, the Hong Kong government has established an online reporting system for abnormal vaccination reactions to encourage medical staff to report rare incidents in a timely manner.
    In addition, the University of Hong Kong's pharmaceutical and pharmacological experts will also cooperate with the government to analyze abnormal events as an independent third party, actively collect data from various medical institutions, and make scientific judgments on special abnormal events.

    Correspondingly, the Hong Kong government has established an online reporting system for abnormal vaccination reactions to encourage medical staff to report rare incidents in a timely manner.
    In addition, medicine and pharmacy experts of the University of Hong Kong will also cooperate with the government as an independent third party to analyze abnormal events.
    The medicine and pharmaceutics experts of the University of Hong Kong will also cooperate with the government to analyze abnormal events as an independent third party.
    Actively collect data from various medical institutions and make scientific judgments on special abnormal events.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> The Hong Kong Special Administrative Region Government also has full confidence in the safety of the two vaccines that have already been launched, and encourages citizens to vaccinate.
    Professor Chen Zhaoshi, Director of the Hong Kong Food and Health Bureau, said: “The two new crown vaccines that have arrived in Hong Kong are all approved by experts.
    The audit believes that it is safe, effective and quality guaranteed, and the benefits of vaccination are higher than the risks.
    "

    The Hong Kong Special Administrative Region Government also has full confidence in the safety of the two vaccines that have already been launched, and encourages citizens to vaccinate.
    Professor Chen Zhaoshi, Director of the Hong Kong Food and Health Bureau, said: “The two new crown vaccines that have arrived in Hong Kong are all approved by experts.
    The audit believes that it is safe, effective and quality guaranteed, and the benefits of vaccination are higher than the risks.
    The benefits of vaccination are higher than the risks.
    "

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> With a population of 1.
    4 billion in mainland China, there is a strong demand for the new crown vaccine.
    On the evening of March 1, Zhong Nanshan, the leader of the high-level expert group of the National Health Commission, said that in order to restore the economy, resume schools, and gradually resume social activities, the entire country cannot be closed for a long time.
    It is necessary to form herd immunity.

    With a population of 1.
    4 billion in mainland China, there is a strong demand for the new crown vaccine.
    On the evening of March 1, Zhong Nanshan, the leader of the high-level expert group of the National Health Commission, said that in order to restore the economy, resume schools, and gradually resume social activities, the entire country cannot be closed for a long time.
    It is necessary to form herd immunity.

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'>

    544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:2em;box-sizing:border-box ;'> From a global perspective, Israel’s vaccinated population accounts for the highest proportion of the total population at 92.
    46%, the UAE has over 60%, the UK has over 30%, and the United States has 22%.
    However, China’s published data shows that the vaccination rate is only 3.
    56% .
    Zhong Nanshan believes: "my country's vaccination rate hopes to reach 40% by the end of June this year.
    Time is short, and we still have a lot of work to do.
    "

    Globally, the number of Israeli vaccination highest proportion of the total population, was 92.
    46 percent, the United Arab Emirates more than 60%, the United Kingdom more than 30%, US 22%, but China has released data show that vaccination rate was 3.
    56 percent , China has Published data shows that the vaccination rate is only 3.
    56% .
    Zhong Nanshan believes: "my country's vaccination rate hopes to reach 40% by the end of June this year.
    Time is short, and we still have a lot of work to do.
    "
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.